Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted 2023 FDA approvals: unprecedented volume at moderate value Dihexa Peptide in Austin, TX Saving Face DIHEXA Research Capsules Peptide Tech EllieMD Dihexa FDA's Overreach on Compounded Peptides